Comparative Pharmacology
Head-to-head clinical analysis: DEXTROSE 7 7 IN PLASTIC CONTAINER versus NORMOSOL M AND DEXTROSE 5 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DEXTROSE 7 7 IN PLASTIC CONTAINER versus NORMOSOL M AND DEXTROSE 5 IN PLASTIC CONTAINER.
DEXTROSE 7.7% IN PLASTIC CONTAINER vs NORMOSOL-M AND DEXTROSE 5% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dextrose is a simple sugar that provides a source of calories and fluid for intravenous administration. It increases blood glucose levels, enhancing cellular metabolism and energy production via the glycolytic pathway and subsequent oxidative phosphorylation.
Normosol-M and Dextrose 5% is a balanced electrolyte solution with dextrose. It provides free water, electrolytes, and a source of calories. The dextrose is metabolized to carbon dioxide and water, producing energy. The electrolytes help maintain or restore extracellular fluid balance.
Intravenous infusion. Typical adult dose is 500-1000 mL of 7.7% dextrose solution infused at a rate of 100-200 mL/hour, titrated to clinical response and serum glucose levels.
Intravenous infusion; dose determined by fluid and electrolyte needs; typical adult rate: 100-200 mL/hour; maximum rate dependent on clinical condition.
None Documented
None Documented
30-60 minutes for blood glucose to return to baseline after infusion cessation; clinical context: rapid metabolism via glycolysis.
Not applicable; components are endogenous substances with rapid clearance; dextrose half-life ~15-30 min in normal glucose metabolism.
Renal: 100% as CO2 and water; no unchanged dextrose excreted in urine under normal conditions.
Renal: Electrolytes and dextrose are excreted renally; dextrose is metabolized to CO2 and water, with no significant fecal or biliary elimination.
Category C
Category C
Intravenous Fluid
Intravenous Fluid